KuruvillaMCheriparambilMD

Adult Congenital Heart Disease, Cardiac Electrophysiology

Physician

Dr. Cheriparambil is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
310 Gaslight Blvd
Lufkin, TX 75904
Phone+1 936-632-8787

Fax+1 936-632-8832

New York Presbyterian Hospital(Cornell Campus)/Coney Island HospitalFellowship, Cardiovascular Disease, 1997 - 2000
New York-Presbyterian Brooklyn Methodist HospitalResidency, Internal Medicine, 1993 - 1996
B.J. Medical College - University of PuneClass of 1981

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013

PubMed

14 citations
Acute Reversible Cardiomyopathy and Thromboembolism After Cisplatin and 5-Fluorouracil Chemotherapy A Case Report
Kuruvilla Mani Cheriparambil, Hemalatha Vasireddy, Anita Kuruvilla, Boris Gambarin, Majesh Makan
Angiology. 2000-10-01
31 citations
Prolonged QRS duration (QRS ≥170 ms) and left axis deviation in the presence of left bundle branch block: A marker of poor left ventricular systolic function ?
Mithilesh K. Das, Kuruvilla Cheriparambil, Ashwini Bedi, John Kassotis, C.V.R. Reddy
American Heart Journal. 2001-11-01
7 citations
Cardioversion of atrial fibrillation with ibutilide: when is it most effective?
Mithilesh K. Das, Kuruvilla Cheriparambil, Ashwini Bedi, John Kassotis, C.V.R. Reddy
Clinical Cardiology. 2002-09-01

PRINCIPAL INVESTIGATOR: CLINICAL RESEARCH TRIALSPrincipal Investigator: 1) ( Livingston site) 2011 CACZ885M2301, CANTOS-- 2) Principal Investigator ( Livingston site) : 2011-2017 CLCZ696B2314, PARADIGM-HF 3) Principal Investigator: ( Livingston site ) recently concluded 2019 PARAGON study Entresto in preserved EF heart failure (CHFpEF)2011 - Present